• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人、猪和牛超长效胰岛素:在正常人体内的皮下注射。

Human, porcine and bovine ultralente insulin: subcutaneous administration in normal man.

作者信息

Owens D R, Vora J P, Heding L G, Luzio S, Ryder R E, Atiea J, Hayes T M

出版信息

Diabet Med. 1986 Jul-Aug;3(4):326-9. doi: 10.1111/j.1464-5491.1986.tb00773.x.

DOI:10.1111/j.1464-5491.1986.tb00773.x
PMID:2949920
Abstract

Six normal subjects received subcutaneous human, porcine, and bovine ultralente insulin (0.30 U/kg) and diluent (control) in randomized order. Plasma glucose, C-peptide, and insulin were measured for 32 h after injection. From 10 h onward human ultralente produced significantly lower plasma glucose levels (p less than 0.05-0.01) compared to bovine ultralente. Porcine ultralente produced an intermediate hypoglycaemic response up to 16 h and was similar to the bovine insulin from 24-32 h. Estimated exogenous insulin concentration was higher (p less than 0.05-0.001) following human ultralente compared to bovine ultralente between 2 and 22 h after injection. Up to 24 h the porcine preparation led to intermediate insulin levels, but becoming identical to bovine ultralente from 28-32 h. Peak mean exogenous insulin values for human, porcine, and bovine ultralente were 0.054, 0.044, and 0.023 nmol/l at 14, 16, and 18 h, respectively, reaching 0.022, 0.013, and 0.013 nmol/l at 32 h. The different pharmacokinetic behaviour of human and bovine ultralente insulin must be considered when initiating treatment with human ultralente or transferring patients from bovine to human ultralente.

摘要

六名正常受试者按随机顺序接受皮下注射人、猪和牛的超长效胰岛素(0.30U/kg)及稀释剂(对照)。注射后32小时内测定血浆葡萄糖、C肽和胰岛素水平。从10小时起,与人超长效胰岛素相比,牛超长效胰岛素使血浆葡萄糖水平显著降低(p<0.05 - 0.01)。猪超长效胰岛素在16小时内产生中等程度的降血糖反应,在24 - 32小时与牛胰岛素相似。注射后2至22小时,与人超长效胰岛素相比,牛超长效胰岛素的估计外源性胰岛素浓度更高(p<0.05 - 0.001)。直至24小时,猪制剂导致中等胰岛素水平,但在28 - 32小时与牛超长效胰岛素相同。人、猪和牛超长效胰岛素的平均外源性胰岛素峰值分别在14、16和18小时为0.054、0.044和0.023nmol/l,在32小时分别降至0.022、0.013和0.013nmol/l。开始用人超长效胰岛素治疗或从牛超长效胰岛素转换为用人超长效胰岛素治疗患者时,必须考虑人及牛超长效胰岛素不同的药代动力学行为。

相似文献

1
Human, porcine and bovine ultralente insulin: subcutaneous administration in normal man.人、猪和牛超长效胰岛素:在正常人体内的皮下注射。
Diabet Med. 1986 Jul-Aug;3(4):326-9. doi: 10.1111/j.1464-5491.1986.tb00773.x.
2
The subcutaneous absorption of human and bovine ultralente insulin formulations.人及牛超长效胰岛素制剂的皮下吸收情况
Diabet Med. 1985 Sep;2(5):355-9. doi: 10.1111/j.1464-5491.1985.tb00650.x.
3
Use of beef ultralente for basal insulin delivery: plasma insulin concentrations after chronic ultralente administration in patients with IDDM.使用超长效牛胰岛素进行基础胰岛素给药:IDDM患者长期使用超长效胰岛素后的血浆胰岛素浓度。
Diabetes Care. 1986 Mar-Apr;9(2):120-3. doi: 10.2337/diacare.9.2.120.
4
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.皮下注射长效人胰岛素类似物甘精胰岛素、中性精蛋白锌胰岛素和超长效人胰岛素以及持续皮下输注赖脯胰岛素的药代动力学和药效学
Diabetes. 2000 Dec;49(12):2142-8. doi: 10.2337/diabetes.49.12.2142.
5
A comparison of human ultralente- and lente-based twice-daily injection regimens.
Diabet Med. 1989 Aug;6(6):496-501. doi: 10.1111/j.1464-5491.1989.tb01216.x.
6
The use of human ultralente is limited by great intraindividual variability in overnight plasma insulin profiles.人超长效胰岛素的使用受到夜间血浆胰岛素水平个体内差异很大的限制。
Scand J Clin Lab Invest. 2000 Aug;60(5):341-7. doi: 10.1080/003655100750019242.
7
Comparison of the safety and effectiveness of human and bovine long-acting insulins.人用和牛用长效胰岛素的安全性与有效性比较。
Diabetes Res. 1989 Nov;12(3):131-4.
8
Miscibility of human and bovine ultralente insulin with soluble insulin.人及牛超长效胰岛素与可溶性胰岛素的混溶性
Br Med J (Clin Res Ed). 1984 Dec 15;289(6459):1656-7. doi: 10.1136/bmj.289.6459.1656-a.
9
Human ultralente insulin: a comparison with porcine lente insulin as a twice-daily insulin in insulin-dependent diabetic patients with fasting hyperglycaemia.
Diabetes Res. 1986 Jun;3(5):263-8.
10
Comparison of two ultralente insulin preparations with protamine zinc insulin in clinically normal cats.两种超长效胰岛素制剂与精蛋白锌胰岛素在临床健康猫中的比较。
Am J Vet Res. 1994 Jan;55(1):127-31.

引用本文的文献

1
The evolution of insulin glargine and its continuing contribution to diabetes care.甘精胰岛素的演变及其对糖尿病治疗的持续贡献。
Drugs. 2014 Jun;74(8):911-27. doi: 10.1007/s40265-014-0226-4.
2
A subcutaneous insulin pharmacokinetic model for computer simulation in a diabetes decision support role: validation and simulation.一种用于糖尿病决策支持的皮下胰岛素药代动力学计算机模拟模型:验证与模拟
J Diabetes Sci Technol. 2008 Jul;2(4):672-80. doi: 10.1177/193229680800200418.
3
A subcutaneous insulin pharmacokinetic model for computer simulation in a diabetes decision support role: model structure and parameter identification.
一种用于糖尿病决策支持的皮下胰岛素药代动力学计算机模拟模型:模型结构与参数识别
J Diabetes Sci Technol. 2008 Jul;2(4):658-71. doi: 10.1177/193229680800200417.
4
Is human insulin without effect in the diabetic rat?人胰岛素对糖尿病大鼠无效吗?
Diabetologia. 1995 Dec;38(12):1492-3. doi: 10.1007/BF00400619.
5
Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use.
Drugs. 1987 Sep;34(3):350-71. doi: 10.2165/00003495-198734030-00003.